In combination with our further results that higher expression of IRAK1 was associated with shorter overall survival and disease-free survival (although for disease-free survival there was only a slight trend without statistical significance), it was proposed that IRAK1 could be a significant biomarker for the prognosis of hepatocellular carcinoma. Here, IRAK1 is linked to hepatocellular carcinoma.